Abstract

SENIOR LEADERSHIPThe Senior Leadership of the Kimmel Cancer Center (KCC) is responsible for the overall operation,management, and planning for the Cancer Center. This includes the administrative and managementoversight of activities in support of research within the Center, including the research programs, sharedresources, and clinical activities.The Senior Leadership includes: Director of the KCC - Richard G. Pestell, M .D., Ph.D. Deputy Director for Basic Science Renato Baserga, M.D. Deputy Director for Clinical Science--Walter J. Curran, M.D. Associate Director for Translational Research Bruno Calabretta, M.D., Ph.D. Associate Director for Education - Marja Nevalainen, M.D., Ph.D. Associate Director for Clinical Investigations - Matthew Carabasi, M.D. Associate Director for Clinical Affairs - Leonard Gomella, M.D. Associate Director for Shared Resources - Richard L. Davidson, Ph.D. Associate Director for Diversity Affairs - Edith Mitchell, M.D. Associate Director for Population Science ~ Ronald Myers, Ph.D.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA056036-09
Application #
7712889
Study Section
Subcommittee G - Education (NCI)
Project Start
2008-09-05
Project End
2013-05-31
Budget Start
2008-09-05
Budget End
2009-05-31
Support Year
9
Fiscal Year
2008
Total Cost
$159,498
Indirect Cost

  Institution

Name
Thomas Jefferson University
Department
Type
DUNS #
053284659
City
Philadelphia
State
PA
Country
United States
Zip Code
19107

  Publications

Sullivan-Reed, Katherine; Bolton-Gillespie, Elisabeth; Dasgupta, Yashodhara et al. (2018) Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells. Cell Rep 23:3127-3136
Lu, Huimin; Bowler, Nicholas; Harshyne, Larry A et al. (2018) Exosomal ?v?6 integrin is required for monocyte M2 polarization in prostate cancer. Matrix Biol 70:20-35
Lapadula, Dominic; Farias, Eduardo; Randolph, Clinita E et al. (2018) Effects of Oncogenic G?q and G?11 Inhibition by FR900359 in Uveal Melanoma. Mol Cancer Res :
Vite, Alexia; Zhang, Caimei; Yi, Roslyn et al. (2018) ?-Catenin-dependent cytoskeletal tension controls Yap activity in the heart. Development 145:
McNair, Christopher; Xu, Kexin; Mandigo, Amy C et al. (2018) Differential impact of RB status on E2F1 reprogramming in human cancer. J Clin Invest 128:341-358
Garcia, Samantha A; Lebrun, Aurore; Kean, Rhonda B et al. (2018) Clearance of attenuated rabies virus from brain tissues is required for long-term protection against CNS challenge with a pathogenic variant. J Neurovirol 24:606-615
Vido, Michael J; Le, Kaitlyn; Hartsough, Edward J et al. (2018) BRAF Splice Variant Resistance to RAF Inhibitor Requires Enhanced MEK Association. Cell Rep 25:1501-1510.e3
Brody, Jonathan R; Dixon, Dan A (2018) Complex HuR function in pancreatic cancer cells. Wiley Interdiscip Rev RNA 9:e1469
Liao, Lili; Liu, Zongzhi Z; Langbein, Lauren et al. (2018) Multiple tumor suppressors regulate a HIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancer. Elife 7:
Heeke, Arielle L; Pishvaian, Michael J; Lynce, Filipa et al. (2018) Prevalence of Homologous Recombination-Related Gene Mutations Across Multiple Cancer Types. JCO Precis Oncol 2018:

Showing the most recent 10 out of 807 publications